Cargando…

Clinical Characteristics and Treatment Outcome of 485 Patients with Nonfunctioning Pituitary Macroadenomas

Background. Nonfunctioning pituitary adenomas (NFPAs) are the most common benign lesions of the pituitary gland. Objective. To describe our experience with the management of NFPA. Study Design and Methods. Retrospective evaluation of NFPA patients managed between 2008 and 2013. We analyzed data rega...

Descripción completa

Detalles Bibliográficos
Autores principales: Vargas, Guadalupe, Gonzalez, Baldomero, Ramirez, Claudia, Ferreira, Aldo, Espinosa, Etual, Mendoza, Victoria, Guinto, Gerardo, Lopez-Felix, Blas, Zepeda, Erick, Mercado, Moisés
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4337176/
https://www.ncbi.nlm.nih.gov/pubmed/25737722
http://dx.doi.org/10.1155/2015/756069
_version_ 1782358575871426560
author Vargas, Guadalupe
Gonzalez, Baldomero
Ramirez, Claudia
Ferreira, Aldo
Espinosa, Etual
Mendoza, Victoria
Guinto, Gerardo
Lopez-Felix, Blas
Zepeda, Erick
Mercado, Moisés
author_facet Vargas, Guadalupe
Gonzalez, Baldomero
Ramirez, Claudia
Ferreira, Aldo
Espinosa, Etual
Mendoza, Victoria
Guinto, Gerardo
Lopez-Felix, Blas
Zepeda, Erick
Mercado, Moisés
author_sort Vargas, Guadalupe
collection PubMed
description Background. Nonfunctioning pituitary adenomas (NFPAs) are the most common benign lesions of the pituitary gland. Objective. To describe our experience with the management of NFPA. Study Design and Methods. Retrospective evaluation of NFPA patients managed between 2008 and 2013. We analyzed data regarding clinical presentation, imaging diagnosis, hormonal status, surgical, radiotherapeutic, and pharmacological treatment, and outcome. Results. 485 patients (54% men, mean age 53 ± 14 years) were followed for a median of 6.5 years. Visual field abnormalities and headaches were the presenting complaints in 87% and 66%, respectively. The diagnosis of NFPA was made incidentally in 6.2%, and 8% presented with clinical evidence of apoplexy. All patients harbored macroadenomas, with a median volume of 10306 mm(3); 57.9% had supra- or parasellar invasion and 19.6% had tumors larger than 4 cm. Central hypothyroidism, hypogonadism, and hypocortisolism were present in 47.2%, 35.9%, and 27.4%, respectively. Surgical resection was performed at least once in 85.7%. Tumor persistence was documented in 27% and was related to the size and invasiveness of the lesion. In selected cases, radiotherapy proved to be effective in controlling or preventing tumor growth. Conclusions. The diagnosis and treatment of NFPA are complex and require a multidisciplinary approach.
format Online
Article
Text
id pubmed-4337176
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-43371762015-03-03 Clinical Characteristics and Treatment Outcome of 485 Patients with Nonfunctioning Pituitary Macroadenomas Vargas, Guadalupe Gonzalez, Baldomero Ramirez, Claudia Ferreira, Aldo Espinosa, Etual Mendoza, Victoria Guinto, Gerardo Lopez-Felix, Blas Zepeda, Erick Mercado, Moisés Int J Endocrinol Research Article Background. Nonfunctioning pituitary adenomas (NFPAs) are the most common benign lesions of the pituitary gland. Objective. To describe our experience with the management of NFPA. Study Design and Methods. Retrospective evaluation of NFPA patients managed between 2008 and 2013. We analyzed data regarding clinical presentation, imaging diagnosis, hormonal status, surgical, radiotherapeutic, and pharmacological treatment, and outcome. Results. 485 patients (54% men, mean age 53 ± 14 years) were followed for a median of 6.5 years. Visual field abnormalities and headaches were the presenting complaints in 87% and 66%, respectively. The diagnosis of NFPA was made incidentally in 6.2%, and 8% presented with clinical evidence of apoplexy. All patients harbored macroadenomas, with a median volume of 10306 mm(3); 57.9% had supra- or parasellar invasion and 19.6% had tumors larger than 4 cm. Central hypothyroidism, hypogonadism, and hypocortisolism were present in 47.2%, 35.9%, and 27.4%, respectively. Surgical resection was performed at least once in 85.7%. Tumor persistence was documented in 27% and was related to the size and invasiveness of the lesion. In selected cases, radiotherapy proved to be effective in controlling or preventing tumor growth. Conclusions. The diagnosis and treatment of NFPA are complex and require a multidisciplinary approach. Hindawi Publishing Corporation 2015 2015-02-08 /pmc/articles/PMC4337176/ /pubmed/25737722 http://dx.doi.org/10.1155/2015/756069 Text en Copyright © 2015 Guadalupe Vargas et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Vargas, Guadalupe
Gonzalez, Baldomero
Ramirez, Claudia
Ferreira, Aldo
Espinosa, Etual
Mendoza, Victoria
Guinto, Gerardo
Lopez-Felix, Blas
Zepeda, Erick
Mercado, Moisés
Clinical Characteristics and Treatment Outcome of 485 Patients with Nonfunctioning Pituitary Macroadenomas
title Clinical Characteristics and Treatment Outcome of 485 Patients with Nonfunctioning Pituitary Macroadenomas
title_full Clinical Characteristics and Treatment Outcome of 485 Patients with Nonfunctioning Pituitary Macroadenomas
title_fullStr Clinical Characteristics and Treatment Outcome of 485 Patients with Nonfunctioning Pituitary Macroadenomas
title_full_unstemmed Clinical Characteristics and Treatment Outcome of 485 Patients with Nonfunctioning Pituitary Macroadenomas
title_short Clinical Characteristics and Treatment Outcome of 485 Patients with Nonfunctioning Pituitary Macroadenomas
title_sort clinical characteristics and treatment outcome of 485 patients with nonfunctioning pituitary macroadenomas
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4337176/
https://www.ncbi.nlm.nih.gov/pubmed/25737722
http://dx.doi.org/10.1155/2015/756069
work_keys_str_mv AT vargasguadalupe clinicalcharacteristicsandtreatmentoutcomeof485patientswithnonfunctioningpituitarymacroadenomas
AT gonzalezbaldomero clinicalcharacteristicsandtreatmentoutcomeof485patientswithnonfunctioningpituitarymacroadenomas
AT ramirezclaudia clinicalcharacteristicsandtreatmentoutcomeof485patientswithnonfunctioningpituitarymacroadenomas
AT ferreiraaldo clinicalcharacteristicsandtreatmentoutcomeof485patientswithnonfunctioningpituitarymacroadenomas
AT espinosaetual clinicalcharacteristicsandtreatmentoutcomeof485patientswithnonfunctioningpituitarymacroadenomas
AT mendozavictoria clinicalcharacteristicsandtreatmentoutcomeof485patientswithnonfunctioningpituitarymacroadenomas
AT guintogerardo clinicalcharacteristicsandtreatmentoutcomeof485patientswithnonfunctioningpituitarymacroadenomas
AT lopezfelixblas clinicalcharacteristicsandtreatmentoutcomeof485patientswithnonfunctioningpituitarymacroadenomas
AT zepedaerick clinicalcharacteristicsandtreatmentoutcomeof485patientswithnonfunctioningpituitarymacroadenomas
AT mercadomoises clinicalcharacteristicsandtreatmentoutcomeof485patientswithnonfunctioningpituitarymacroadenomas